Upcoming IPOs
All IPOs

Accretion Nutraveda IPO Review

BSE SMEListed

Healthcare Service Provider · Listed on BSE · 28 Jan 2026 - 30 Jan 2026

Jagat JoshiJagat Joshi
October 30, 2026
Issue Size
25.00 Cr
Price Band
₹122.00 - ₹129.00
Lot Size
1000 Shares
Min Investment
₹2,58,000
GMP
₹16
Subscription
1.83x
₹30.24 Cr
IPO Timeline
IPO OpensDONE
28 Jan 2026
IPO ClosesDONE
30 Jan 2026
Basis of AllotmentDONE
02 Feb 2026
RefundsDONE
03 Feb 2026
Demat CreditDONE
03 Feb 2026
ListingDONE
04 Feb 2026

About Accretion Nutraveda IPO

Accretion Nutraveda IPO open date is January 28, 2026 and the IPO will close on January 30, 2026. Accretion Nutraveda IPO is a Book Build Issue. The company to raise around ₹24.77 crores via IPO that comprises fresh issue of ₹24.77 crores and offer for sale up to [.] equity shares with face value of ₹10 each.

Accretion Nutraveda IPO price band is ₹122 to ₹129 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Accretion Nutraveda IPO to list on BSE SME on February 4, 2026. The allotment of Accretion Nutraveda IPO date is February 2, 2026.

The company reported revenue of ₹16.06 crores in 2025 against ₹5.20 crores in 2024. The company reported profit of ₹2.61 crores in 2025 against profit of ₹0.82 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.

Advertisement
Back to IPO Details

IPO Recommendations

Consensus review from market research firms & brokerage analysts

0
analysts
0
Apply
0
May Apply
0
Neutral
0
Avoid

Accretion Nutraveda Review

No broker reviews have been published for this IPO yet.

User Reviews

Community Sentiment
Votes submitted by verified retail investors
0
votes
0
Apply
0
May Apply
0
Neutral
0
Avoid

Add Your Review

What is your recommendation for this IPO?

Loading options…

How would you rate this IPO (1 to 5)?

3
Disclaimer:

The IPO reviews, and recommendations published on this page are provided by respective authors, brokers, analysts, and contributors. These views do not represent the views of IPO Watch, its management, or its staff.

IPO Watch does not guarantee about the information or recommendations provided by third-party contributors. Use this content for informational and educational purposes only.

Investors are advised to do their own research, check offer documents, and consult a qualified financial adviser before making investment decisions.

IPO Watch reserves the right to review, modify, or remove any content that does not meet the editorial guidelines.

Advertisement

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by